These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1989 related items for PubMed ID: 29733831

  • 1. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M.
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [Abstract] [Full Text] [Related]

  • 2. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, Loomba R, Chalasani N, Kowdley K, Hameed B, Wilson LA, Yates KP, Belt P, Lazo M, Kleiner DE, Behling C, Tonascia J, NASH Clinical Research Network (CRN).
    N Engl J Med; 2021 Oct 21; 385(17):1559-1569. PubMed ID: 34670043
    [Abstract] [Full Text] [Related]

  • 3. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Chin J, Huang Y, Adams LA.
    Liver Int; 2018 Oct 21; 38(10):1793-1802. PubMed ID: 29575516
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
    Vilar-Gomez E, Calzadilla-Bertot L, Wong VW, Castellanos M, Aller-de la Fuente R, Eslam M, Wong GL, George J, Romero-Gomez M, Adams LA.
    Clin Gastroenterol Hepatol; 2021 Jan 21; 19(1):136-145.e6. PubMed ID: 32389886
    [Abstract] [Full Text] [Related]

  • 7. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
    Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP, George J.
    Hepatology; 2011 Oct 21; 54(4):1208-16. PubMed ID: 21688282
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
    Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, Gordon SC.
    Aliment Pharmacol Ther; 2020 Jun 21; 51(11):1149-1159. PubMed ID: 32372515
    [Abstract] [Full Text] [Related]

  • 9. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
    Petta S, Sebastiani G, Viganò M, Ampuero J, Wai-Sun Wong V, Boursier J, Berzigotti A, Bugianesi E, Fracanzani AL, Cammà C, Enea M, Grottes MD, Di Marco V, Younes R, Keyrouz A, Mazzola S, Mendoza Y, Pennisi G, Romero-Gomez M, Craxì A, de Ledinghen V.
    Clin Gastroenterol Hepatol; 2021 Apr 21; 19(4):806-815.e5. PubMed ID: 32621970
    [Abstract] [Full Text] [Related]

  • 10. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
    Orman ES, Roberts A, Ghabril M, Nephew L, Desai AP, Patidar K, Chalasani N.
    JAMA Netw Open; 2019 Jun 05; 2(6):e196412. PubMed ID: 31251379
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, Deschenes M, Ghali P.
    PLoS One; 2015 Jun 05; 10(6):e0128774. PubMed ID: 26083565
    [Abstract] [Full Text] [Related]

  • 12. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A, Al-Kurd A, Wilson R, Bena J, Fayazzadeh H, Singh T, Albaugh VL, Shariff FU, Rodriguez NA, Jin J, Brethauer SA, Dasarathy S, Alkhouri N, Schauer PR, McCullough AJ, Nissen SE.
    JAMA; 2021 Nov 23; 326(20):2031-2042. PubMed ID: 34762106
    [Abstract] [Full Text] [Related]

  • 13. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT, Chan WK, Wong GL, Chan AW, Nik Mustapha NR, Chan SL, Chong CC, Mahadeva S, Shu SS, Lai PB, Chan HL, Wong VW.
    Am J Gastroenterol; 2020 Jun 23; 115(6):867-875. PubMed ID: 32149781
    [Abstract] [Full Text] [Related]

  • 14. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K, Nilsson PM, Lindgren S.
    Scand J Gastroenterol; 2014 Sep 23; 49(9):1111-8. PubMed ID: 24990583
    [Abstract] [Full Text] [Related]

  • 15. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Simon TG, Roelstraete B, Sharma R, Khalili H, Hagström H, Ludvigsson JF.
    Hepatology; 2021 Nov 23; 74(5):2410-2423. PubMed ID: 33811766
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
    Huang Y, de Boer WB, Adams LA, MacQuillan G, Bulsara MK, Jeffrey GP.
    Intern Med J; 2015 Jan 23; 45(1):48-54. PubMed ID: 25371273
    [Abstract] [Full Text] [Related]

  • 17. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
    Marengo A, Jouness RI, Bugianesi E.
    Clin Liver Dis; 2016 May 23; 20(2):313-24. PubMed ID: 27063271
    [Abstract] [Full Text] [Related]

  • 18. Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Tan HK, Teng MLP, Soh AYS, Cheo SHY, Fook-Chong S, Goh GBB, Tan CK, Wong GW, Lee GH, Chang JPE.
    Am J Gastroenterol; 2021 Jul 01; 116(7):1437-1446. PubMed ID: 33834737
    [Abstract] [Full Text] [Related]

  • 19. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
    Simon TG, Roelstraete B, Khalili H, Hagström H, Ludvigsson JF.
    Gut; 2021 Jul 01; 70(7):1375-1382. PubMed ID: 33037056
    [Abstract] [Full Text] [Related]

  • 20. Quantitative fibrosis estimation by image analysis predicts development of decompensation, composite events and defines event-free survival in chronic hepatitis B patients.
    Bihari C, Rastogi A, Sen B, Bhadoria AS, Maiwall R, Sarin SK.
    Hum Pathol; 2016 Sep 01; 55():63-71. PubMed ID: 27189343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.